Intracranial hemorrhage: Diagnosis and management

Neurologic Clinics

Volumn 30, Issue 1, 2012, Pages 211-240

  Freeman, William David ^a   Aguilar, Maria I ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Epidural hematoma; Intracerebral hemorrhage; Intracranial hemorrhage; Intraparenchymal hemorrhage; Subarachnoid hemorrhage; Subdural hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENALAPRILAT; ESMOLOL; FAMOTIDINE; FOSPHENYTOIN SODIUM; LABETALOL; LORAZEPAM; MANNITOL; NIMODIPINE; OMEPRAZOLE; PETHIDINE; PHENYTOIN; PLACEBO; PROTAMINE; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

ANEURYSM RUPTURE; BLOOD PRESSURE REGULATION; BODY TEMPERATURE; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; EPIDURAL HEMATOMA; FEVER; HUMAN; HYDROCEPHALUS; HYPERTENSION; INTRACRANIAL ANEURYSM; INTRACRANIAL HYPERTENSION; INTRAPARENCHYMAL HEMORRHAGE; NONHUMAN; NUTRITION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; SEIZURE; SHIVERING; STRESS ULCER; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; BRAIN; RADIOGRAPHY;

BRAIN; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES;

EID: 84856259109     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.09.002     Document Type: Review

References (88)

1. Broderick J.P., Connelly S., Feldman E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:2001.
2. Morgenstern L.B., Hemphill J.C., Anderson C., et al. Association/American Stroke Association Guideline for Healthcare Professionals From the American Heart Guidelines for the Management of Spontaneous Intracerebral Hemorrhage. Stroke 2010, 41:2108-2129. 10.1161/STR.0b013e3181ec611b.
3. Bederson J.B., Connolly E.S., Batjer H.H., et al. American Heart Association Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40(3):994-1025.
4. Lee S.H., Ryu W.S., Roh J.K. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009, 72(2):171-176.
5. Brain Trauma Organization Guidelines for TBI and ICH. Guidelines for the Management of Severe Traumatic Brain Injury. 3rd edition. Available at: Accessed September 29, 2011. https://www.braintrauma.org/coma-guidelines/.
6. Reynolds S.F., Heffner J. Airway management of the critically ill patient: rapid-sequence intubation. Chest 2005, 127(4):1397-1412.
7. Brott T., Broderick J.P., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1-5.
8. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004, 164:880-884.
9. Aguilar M.I., Hart R.G., Kase C.S., et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007, 82(1):82-92.
10. Larive L.L., Rhoney D.H., Parker D., et al. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care 2004, 1(4):435-440.
11. Qureshi A.I., Wilson D.A., Traystman R.J. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery 1999, 44(5):1055-1063.
12. Ogden A.T., Mayer S.A., Connolly E.S. Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005, 57(2):207-215.
13. Qureshi A.I., Suarez J.I., Bhardwaj A., et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26:440-446.
14. Suarez J.I., Qureshi A.I., Bhardwaj A., et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998, 26:1118-1122.
15. Polderman K. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet 2008, 371:1955-1969.
16. Rossetti A.O., Oddo M. The neuro-ICU patient and electroencephalography paroxysms: if and when to treat. Curr Opin Crit Care 2010, [Epub ahead of print].
17. Carhuapoma J.R., Gupta K., Coplin W.M., et al. Treatment of refractory fever in the neurosciences critical care unit using a novel, water-circulating cooling device. A single-center pilot experience. JNeurosurg Anesthesiol 2003, 15(4):313-318.
18. Diringer M.N., Neurocritical Care Fever Reduction Trial Group Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 2004, 32(2):559-564.
19. Leira R., Davalos A., Silva Y., Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004, 63(3):461-467.
20. Marion D.W. Controlled normothermia in neurologic intensive care. Crit Care Med 2004, 32(Suppl 2):S43-S45.
21. Ritter A.M., Robertson C.S. Cerebral metabolism. Neurosurg Clin N Am 1994, 5(4):633-645.
22. Mayer S.A., Kowalski R.G., Presciutti M., et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med 2004, 32(12):2508-2515.
23. Doufas A.G., Sessler D.I. Physiology and clinical relevance of induced hypothermia. Neurocrit Care 2004, 1(4):489-498.
24. Hart R.G., Tonarelli S.B., Pearce L.A. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005, 36(7):1588-1593.
25. Sjoblom L., Hardemark H.G., Lindgren A., et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001, 32:2567-2574.
26. Broderick J.P., Brott T.G., Tomsick T., et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. JNeurosurg 1993, 78:188-191.
27. Aguilar M.I., Freeman W.D. Treatment of coagulopathy in intracranial hemorrhage. Curr Treat Options Neurol 2010, 12(2):113-128.
28. Broderick J.P., Brott T.G., Duldner J.E., et al. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993, 24:987-993.
29. AquaMEPHYTON. Physician's Desk Reference, PDR.net; 2001.
30. Riegert-Johnson D.L., Volcheck G.W. The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. Ann Allergy Asthma Immunol 2002, 89(4):400-406.
31. Fiore L.D., Scola M.A., Cantillon C.E., et al. Anaphylactoid reactions to vitamin K. JThromb Thrombolysis 2001, 11(2):175-183.
32. Freeman W.D., Aguilar M.I. Management of warfarin-related intracerebral hemorrhage. Expert Rev Neurother 2008, 8(2):271-290.
33. Ansell J., Hirsh J., Hylek E., et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133:160S-198S.
34. Olson J.D. Mechanisms of hemostasis. Effect on intracerebral hemorrhage. Stroke 1993, 24(Suppl 12):I109-I114.
35. Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. NEngl J Med 2003, 349:675-683.
36. Dabigatran [package insert]. Rhein (Germany): Boehringer Ingelheim.
37. Connolly S.J., Ezekowitz M.D., Yusuf S., RELY Trial Investigators, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEngl J Med 2009, 361:1139-1151.
38. Drug information unit request. Boehringer Ingelheim Pharmaceuticals, Inc.
39. van Ryn J., Stangier J., Haertter S., et al. Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010, 103:1116-1127.
40. Smith E.E., Rosand J., Knudsen K.A., et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002, 59:193-197.
41. Jeerakathil T., Wolf P.A., Beiser A., et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004, 35:1831-1835.
42. Nighoghossian N., Hermier M., Adeleine P., et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 2002, 33:735-742.
43. Lee S.H., Bae H.J., Kwon S.J., et al. Cerebral Microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004, 62:72-76.
44. Woo D., Sauerbeck L.R., Kissela B.M., et al. Genetic and environmental risk factors for intracerebral hemorrhage. Stroke 2002, 33:1190-1196.
45. Qureshi A.I., Tuhrim S., Broderick J.P., et al. Spontaneous intracerebral hemorrhage. NEngl J Med 2001, 344(19):1450-1460.
46. Fisher C.M. Pathological observations in hypertensive cerebral hemorrhage. JNeuropathol Exp Neurol 1971, 30:536-550.
47. Garcia J.H., Ho K.L. Pathology of hypertensive cerebral arteriopathy. Neurosurg Clin N Am 1992, 3:497-507.
48. Greenberg S.M., Eng J.A., Ning M., et al. Hemorrhage burden predicts recurrent intracerebral after lobar hemorrhage. Stroke 2004, 35:1415-1420.
49. Walker D.A., Rubino F. Routine use of gradient-echo MRI to screen for cerebral amyloid angiopathy in elderly patients. Am J Roentgenol 2004, 182(6):1547-1550.
50. Qureshi A.I., Bliwise D.L., Bliwise N.G., et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999, 27(3):480-485.
51. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010, 38(2):637-648.
52. Anderson C.S., Huang Y., Wang J.G., et al. INTERACT Investigators. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008, 7(5):391-399.
53. Kothari R.U., Brott T., Broderick J.P., et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996, 27:1304-1305.
54. Toyoda K., Okada Y., Minematsu K., et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005, 65:1000-1004.
55. Kazui S., Minematsu K., Yamamoto H., et al. Predisposing factors to enlargement of spontaneous intracerebral hemorrhage. Stroke 1997, 28:2370-2375.
56. Ohwaki K., Yano E., Nagashima H., et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004, 35:1364-1367.
57. Naidech A.M., Bendok B.R., Garg R.K., et al. Reduced platelet activity is associated with more intraventricular hemorrhage. Neurosurgery 2009, 65(4):684-688.
58. Mayer S.A., Brun N.C., Begtrup K., Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. NEngl J Med 2005, 352(8):777-785.
59. NovoSeven. [Package Insert].
60. Fewel M.E., Park P. The emerging role of recombinant-activated factor VII in neurocritical care. Neurocrit Care 2004, 1:19-30.
61. Mayer S.A., Brun N.C., Begtrup K., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. NEngl J Med 2008, 358(20):2127-2137.
62. Xi G., Keep R.F., Hoff J.T. Pathophysiology of brain edema formation. Neurosurg Clin N Am 2002, 13(3):371-383.
63. Gebel J.M., Jauch E.C., Brott T.G., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002, 33:2636-2641.
64. Gebel J.M., Jauch E.C., Brott T.G., et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002, 33:2631-2635.
65. Fernandes H.M., Gregson B., Siddique S., et al. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000, 31(10):2511-2516.
66. Mendelow A.D., Gregson B.A., Fernandes H.M., STICH investigators, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365(9457):387-397.
67. Nishihara T., Nagata K., Tanaka S., et al. Newly developed endoscopic instruments for the removal of intracerebral hematoma. Neurocrit Care 2005, 2:67-74.
68. Vespa P., McArthur D., Miller C., et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurologic improvement. Neurocrit Care 2005, 2:274-281.
69. Murthy J.M., Chowdary G.V., Murthy T.V., et al. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocrit Care 2005, 2:258-262.
70. Hanley D.F., Hacke W. Ongoing studies: from critical care and emergency medicine neurology in stroke. Stroke 2005, 36:205.
71. Hemphill J.C., Bonovich D.C., Besmertis L., et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32:891-897.
72. Nates J.L., Niggemeyer L.E., Anderson M.B., et al. Cerebral perfusion pressure monitoring alert!. Crit Care Med 1997, 25:895-896. [letter].
73. Rose J.C., Mayer S.A. Optimizing blood pressure in neurological emergencies. Neurocrit Care 2004, 1(3):287-299.
74. Kistler J.P., Crowell R.M., Davis K.R., et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983, 33(4):424-436.
75. Macdonald R.L., Pluta R.M., Zhang J.H. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 2007, 3(5):256-263.
76. Ullman J.S., Bederson J.B. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Crit Care Clin 1996, 12(3):697-707.
77. Bullock M.R., Chesnut R., Ghajar J., et al. Surgical management of acute subdural hematomas. Neurosurgery 2006, 58:S16-S24. [discussion: Si-iv].
78. Bullock M.R., Chesnut R., Ghajar J., Surgical Management of Traumatic Brain Injury Author Group, et al. Surgical management of acute epidural hematomas. Neurosurgery 2006, 58(Suppl 3):S7-15. [discussion: Si-iv].
79. Koc R.K., Akdemir H., Oktem I.S., et al. Acute subdural hematoma: outcome and outcome prediction. Neurosurg Rev 1997, 20(4):239-244.
80. Wilberger J.E., Harris M., Diamond D.L. Acute subdural hematoma: morbidity, mortality, and operative timing. JNeurosurg 1991, 74(2):212-218.
81. Rabinstein A.A., Chung S.Y., Rudzinski L.A., et al. Seizures after evacuation of subdural hematomas: incidence, risk factors, and functional impact. J Neurosurg 2010, 112(2):455-460.
82. Bender M.B., Christoff N. Nonsurgical treatment of subdural hematomas. Arch Neurol 1974, 31(2):73-79.
83. Engelhard H.H., Andrews C.O., Slavin K.V., et al. Current management of intraventricular hemorrhage. Surg Neurol 2003, 60:15-22.
84. Naff N.J., Carhuapoma J.R., Williams M.A., et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke 2000, 31(4):841-847.
85. Akdemir H., Selcuklu A., Pasaoglu A., et al. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 1995, 18(2):95-100.
86. Coplin W.M., Vinas F.C., Agris J.M., et al. Acohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998, 29(8):1573-1579.
87. Tung M.Y., Ong P.L., Seow W.T., et al. Astudy on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998, 12(3):234-239.
88. Naff N.J., Hanley D.F., Keyl P.M., et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized double-blind, controlled trial. Neurosurgery 2004, 54(3):577-583.